ESTELLE WEBSTER: Open Payments
NPI 1982195186 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,818 in 23 payments from 8 companies in 2025. Trend: 2023 $314 · 2024 $972 · 2025 $1,818
Food & beverage: $1,818
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $539 |
| Axsome Therapeutics, Inc. | 4 | $353 |
| Alkermes, Inc. | 3 | $270 |
| Vanda Pharmaceuticals Inc. | 4 | $253 |
| Braeburn Inc. | 1 | $134 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $33 |
Products named: VRAYLAR, Auvelity, FANAPT, ARISTADA, BRIXADI, COBENFY, VIVITROL, REXULTI.
Industry payments across NY — which companies pay providers there.
